fda warning letters compounding semaglutide news issued 25 to telehealth companies for false and misleading claims about compounded GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of February 17, 2026: Pennsylvania compounding

Heres a summary of non-injection options: Rybelsus Rybelsus is approved by the FDA for type 2 diabetes

D., Black D

What Are the Side Effects of Subcutaneous Injections

Obesity is a life-long, progressive, life-threatening, genetically-related, multi-factorial disease of excess fat storage

Changing habits is a hard thing to suddenly do, but taking small steps to change the way you eat goes a long way in assisting with weight maintenance

For reference, retatrutide titration in these trials followed a slow ramp over 2436 weeks: Weeks 14: 2mg/week Weeks 58: 4mg/week Weeks 912: 8mg/week Week 13+: 12mg/week (for 12mg group) The slow titration is important GI tolerability at higher doses improves significantly with gradual escalation